Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line

Molecular and Cellular Biochemistry

Volumn 365, Issue 1-2, 2012, Pages 29-35

  Parashar, Gaurav ^a   Parashar, Nidarshana Chaturvedi ^b   Capalash, Neena ^a  

^a PANJAB UNIVERSITY   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Cervical cancer; Curcumin; FANCF; Promoter hypomethylation; Resveratrol

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CURCUMIN; DNA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; RESVERATROL;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CPG ISLAND; CYTOTOXICITY; DEMETHYLATION; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; FANCONI ANEMIA; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER;

AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, COMPLEMENTARY; DNA-CYTOSINE METHYLASES; EPIGENESIS, GENETIC; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; HUMANS; INHIBITORY CONCENTRATION 50; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STILBENES; TRANSCRIPTION, GENETIC;

EID: 84860240764     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1240-z     Document Type: Article

References (27)

1. I-W Teng P-C Hou K-D Lee, et al. 2011 Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells Cancer Res 71 13 4653 4663 21518779 10.1158/0008-5472.CAN- 10-3418 1:CAS:528:DC%2BC3MXotlert7o%3D
2. N Wentzensen ME Sherman M Schiffman, et al. 2009 Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science Gynecol Oncol 112 2 293 299 19054549 10.1016/j.ygyno.2008. 10.012 1:CAS:528:DC%2BD1MXntFersA%3D%3D
3. MA Siddique K Nakanishi T Taniguchi, et al. 2001 Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells Exp Hematol 29 1448 1455 11750104 10.1016/S0301-472X(01)00754-8 1:CAS:528: DC%2BD3MXpt1aqsbg%3D
4. F Léveillé E Blom AL Medhurst, et al. 2004 The Fanconi Anemia gene product FANCF is a flexible adaptor protein J Biol Chem 279 38 39421 39430 15262960 10.1074/jbc.M407034200
5. JP De Winter LV Weel J De Groot, et al. 2000 The Fancomi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG Hum Mol Genet 9 18 2665 2674 11063725 10.1093/hmg/9.18.2665
6. T Taniguchi M Tischkowitz N Ameziane, et al. 2003 Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors Nat Med 9 568 574 12692539 10.1038/nm852 1:CAS:528:DC%2BD3sXjtlamtLo%3D
7. CJ Marsit M Liu HH Nelson, et al. 2004 Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival Oncogene 23 1000 1004 14647419 10.1038/sj.onc.1207256 1:CAS:528:DC%2BD2cXntlelsQ%3D%3D
8. G Narayan H Arias-Pulido S Koul, et al. 2003 Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome Mol Cancer 2 24 12773202 10.1186/1476-4598-2-24
9. G Narayan H Arias-Pulido SV Nandula, et al. 2004 Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer Cancer Res 64 2994 2997 15126331 10.1158/0008-5472.CAN-04-0245 1:CAS:528:DC%2BD2cXjs1ehsLc%3D
10. Bakker S T, van de Vrugt HJ, Visser JA et al (2011) FANCF-deficient mice are prone to develop ovarian tumours. J Pathol. doi: 10.1002/path.2992
11. JG Herman A Umar K Polyak, et al. 1998 Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma Proc Natl Acad Sci USA 95 6870 6875 9618505 10.1073/pnas.95.12.6870 1:CAS:528:DyaK1cXjslynu7s%3D
12. B Brueckner RG Boy P Siedlecki, et al. 2005 Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases Cancer Res 65 6305 6311 16024632 10.1158/0008-5472.CAN-04- 2957 1:CAS:528:DC%2BD2MXmt1egsb8%3D
13. MS Soengas P Capodieci D Polsky, et al. 2001 Inactivation of the apoptosis effector Apaf-1 in malignant melanoma Nature 409 207 211 11196646 10.1038/35051606 1:CAS:528:DC%2BD3MXlvFSrsA%3D%3D
14. MF Robert S Morin N Beaulieu, et al. 2003 DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells Nat Genet 33 61 65 12496760 10.1038/ng1068 1:CAS:528:DC%2BD38XpvVeqsL4%3D
15. P Siedlecki RG Boy T Musch, et al. 2006 Discovery of two novel, small-molecule inhibitors of DNA methylation J Med Chem 49 678 683 16420053 10.1021/jm050844z 1:CAS:528:DC%2BD2MXht1Oqu7jP
16. MZ Fang Y Wang N Ai, et al. 2003 Tea polyphenol (-)-epigallocatechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 63 7563 7570 14633667 1:CAS:528: DC%2BD3sXptFOlsrk%3D
17. Z Wang H Chen 2010 Genistein increases gene expression by demethylation of WNT5a promoter in colon cancer cell line SW1116 Anticancer Res 30 4537 4546 21115903 1:CAS:528:DC%2BC3MXhs1ahtw%3D%3D
18. Z Liu S Liu Z Xie, et al. 2009 Modulation of DNA methylation by a sesquiterpene lactone parthenolide J Pharmacol Exp Ther 329 2 505 514 19201992 10.1124/jpet.108.147934 1:CAS:528:DC%2BD1MXlt1Omu7s%3D
19. SR Morey Kinney W Zhang M Pascual, et al. 2009 Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate Cancer Prev Res 2 1065 1075 10.1158/1940-6207.CAPR-09-0010
20. AK Jha M Nikbakht G Parashar, et al. 2010 Reversal of hypermethylation and reactivation of the RARβ2 gene by natural compounds in cervical cancer cell lines Folia Biologica (Praha) 56 195 200 1:STN:280:DC%2BC3M%2FisFymsQ%3D%3D
21. ZF Liu ZL Xie W Jones, et al. 2009 Curcumin is a potent DNA hypomethylation agent Bioorg Med Chem Lett 19 706 709 19112019 10.1016/j.bmcl.2008.12.041
22. YL Liu HP Yang L Gong, et al. 2011 Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines Mol Med Report 4 4 675 679 21484077 1:CAS:528: DC%2BC3MXnsl2ht74%3D
23. JL Medina-Franco F Lopez-Vallejo D Kuck, et al. 2011 Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach Mol Divers 15 2 293 304 20697809 10.1007/s11030-010-9262-5 1:CAS:528:DC%2BC3MXltlejtr8%3D
24. J Heckenkamp D Leszczynski J Schiereck, et al. 1999 Different effects of photodynamic therapy and gamma irradiation on vascular smooth muscle cells and matrix: implications for inhibiting restenosis Arterioscler Thomb Vasc Biol 19 2154 2161 10.1161/01.ATV.19.9.2154 1:CAS:528:DyaK1MXmtFOrt7g%3D
25. E Tokunaga S Okada H Kitao S Shiotani, et al. 2011 Low incidence of methylation of the promoter region of the FANCF gene in Japanese primary breast cancer Breast Cancer 18 2 120 123 19813073 10.1007/s12282-009-0175-z
26. TO Khor Y Huang Tien-Yuan Wu, et al. 2011 Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation Biochem Pharmacol 82 1073 1078 21787756 10.1016/j.bcp.2011.07.065 1:CAS:528:DC%2BC3MXht12qs7fE
27. J Yoo JL Medina-Franco 2011 Homology modeling, docking and structure-based pharmacophore of inhibitors of DNA methyltransferase J Comput Aided Mol Des 25 6 555 567 21660514 10.1007/s10822-011-9441-1 1:CAS:528:DC%2BC3MXosFCgs78%3D